Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : PJ September 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Safety concerns over the potential neurotoxicity of sedatives and analgesics in neonates, often used in neonatal intensive care units, have raised questions at an international level. In the image, newborn in incubator in intensive care

    Use of sedatives and analgesics in infants vary widely across Europe Subscription

    2 OCT 2015 9:25

    A study of neonatal intensive care units in Europe revealed a lack of consistency in the use of sedatives and analgesics, which are potentialy neurotoxic in newborns.

  • Two new drugs marketed by Danish pharmaceutical company Novo Nordisk (flag with logo pictured) to improve blood sugar control in patients with type 1 and type 2 diabetes have been given marketing authority in the US

    US FDA approves two injectable diabetes treatments Subscription

    2 OCT 2015 10:31

    Two drugs that improve blood sugar control in patients with type 1 and type 2 diabetes have been given marketing authority in the United States.

  • Thursday 15 October: RPS Faculty webinar Subscription

    11 SEP 2015 11:13

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: what is the best type of evidence? How much detail do I need to enter into my portfolio? Who should I ask to provide a peer testimonial? Do I need to cover all the competencies? Online 7–8pm. To find out more information and to register and access the webinar, visit the RPS website.

  • Thursday 1 October: RPS Faculty webinar Subscription

    11 SEP 2015 11:12

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: what is the best type of evidence? How much detail do I need to enter into my portfolio? Who should I ask to provide a peer testimonial? Do I need to cover all the competencies? Online 1–2pm. To find out more information and to register and access the webinar, visit the ...

  • The sustainability of the Cancer Drugs Fund Video

    7 OCT 2015 0:51

    Elizabeth Sukkar, the journal’s deputy news editor, asks key opinion leaders from NICE, the ABPI, the NHS and Myeloma UK on the sustainability of the Cancer Drugs Fund considering it is massively over budget.

  • Side effects for Tracleer Subscription

    22 SEP 2015 14:00

    Aminotransferase elevations associated with hepatitis (including possible exacerbation of underlying hepatitis) or jaundice or both has been added as an uncommon adverse reaction in the summary of product characteristics for Tracleer (bosentan monohydrate; Actelion).

  • Side effects and interactions for Fareston Subscription

    22 SEP 2015 14:45

    The summary of product characteristics (SPC) for Fareston (toremifene; Orion) now states that cases of liver injury, including elevation of liver enzymes, hepatitis and jaundice, have been reported with toremifene. Additionally, the amount of lactose per tablet has been amended from 30mg to 28.5mg. The updated SPC also states that, theoretically, the metabolism of toremifene is inhibited by drugs known to inhibit the CYP3A enzyme system. Examples of such drugs are antifungal imidazoles, ...

  • The first national gluten-free food service delivered by community pharmacists is being set up in Scotland as part of the national contract from 1 October 2015. In the image, close-up of packaged gluten-free pasta

    Scotland rolls out gluten-free food service through pharmacies Subscription

    25 SEP 2015 14:21
    Comments (1)

    The first national gluten-free food service delivered by community pharmacists is being set up in Scotland as part of the national contract from 1 October 2015.

  • Reduced shelf life for Cayston Subscription

    22 SEP 2015 14:44

    The shelf life for Cayston (aztreonam) solvent ampoule has been reduced from four to three years. 

  • The Drugs for Neglected Diseases initiative has announced that it aims to spend €650m to deliver treatments for up to 10 diseases. In the image, tsetse mosquitos pictured on a researcher's hand are responsible for the African sleeping sickness

    R&D plan announced for drugs for neglected diseases Subscription

    18 SEP 2015 13:45

    The Drugs for Neglected Diseases initiative, a non-profit research and development organisation, has announced that it aims to spend €650m over the next eight years to deliver 16–18 new treatments.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.